Independent immunodominant and immunorecessive tumor-specific antigens on a malignant tumor: antigenic dissection with cytolytic T cell clones
- PMID: 6187859
Independent immunodominant and immunorecessive tumor-specific antigens on a malignant tumor: antigenic dissection with cytolytic T cell clones
Abstract
We have analyzed the complexity of a unique tumor-specific transplantation antigen expressed by the murine ultraviolet light-induced fibrosarcoma 1591-RE. This tumor is highly immunogenic and is regularly rejected by normal mice. We have derived a cloned cytolytic T cell line showing a reactivity pattern representative of the cytolytic response of the host rejecting this regressor tumor. Using this T cell line (anti-A), variants of 1591-RE (1591-A-) were selected in vitro that had lost the same antigen as progressor variants of 1591-RE selected by the host in vivo. The in vitro derived variant was then used to generate a second T cell clone (anti-B) that recognized an antigen on the parental tumor that had been retained by the variants derived in vitro. Host-selected progressor variants were also found to have retained this antigen. By selecting for variants in vitro from the parental tumor with the anti-B T cell line, it was shown that the two different antigens (A and B) present on the parental tumor were lost independently of each other. Despite the independence of these two antigens, the host T cell response to the parental regressor tumor was invariably restricted to only the "immunodominant" A antigen.
Similar articles
-
Pecking order among tumor-specific antigens.Eur J Immunol. 1984 Feb;14(2):181-7. doi: 10.1002/eji.1830140214. Eur J Immunol. 1984. PMID: 6230244
-
Immune response to progressor variants derived from transfection of an ultraviolet radiation-induced C3H mouse regressor tumor cell line with activated Harvey-ras oncogene.Cancer Res. 1990 Jun 1;50(11):3159-66. Cancer Res. 1990. PMID: 2185882
-
Specificity of antigens on UV radiation-induced antigenic tumor cell variants measured in vitro and in vivo.Cancer Res. 1989 Mar 1;49(5):1207-13. Cancer Res. 1989. PMID: 2465081
-
Surface markers, antigens, and receptors on murine T and B cells: part 1.Crit Rev Immunol. 1982 Jun;3(4):331-69. Crit Rev Immunol. 1982. PMID: 6180863 Review. No abstract available.
-
Lymphocyte-mediated lysis of tumor cells in vitro. Antigen-restricted clonal and unrestricted polyclonal effects.Springer Semin Immunopathol. 1982;5(2):147-59. doi: 10.1007/BF00199793. Springer Semin Immunopathol. 1982. PMID: 6183765 Review. No abstract available.
Cited by
-
Malignant growth in the normal host after variant selection in vitro with cytolytic T-cell lines.Proc Natl Acad Sci U S A. 1984 Apr;81(7):2186-90. doi: 10.1073/pnas.81.7.2186. Proc Natl Acad Sci U S A. 1984. PMID: 6609361 Free PMC article.
-
Immunoselection of structural H-2Kb variants: use of cloned cytolytic T cells to select for loss of a CTL-defined allodeterminant.Immunogenetics. 1986;23(1):52-9. doi: 10.1007/BF00376522. Immunogenetics. 1986. PMID: 3484723
-
Specificity in cancer immunotherapy.Semin Immunol. 2008 Oct;20(5):276-85. doi: 10.1016/j.smim.2008.07.001. Epub 2008 Aug 5. Semin Immunol. 2008. PMID: 18684640 Free PMC article. Review.
-
Antibody phage display libraries: contributions to oncology.Int J Mol Sci. 2012;13(5):5420-5440. doi: 10.3390/ijms13055420. Epub 2012 May 4. Int J Mol Sci. 2012. PMID: 22754305 Free PMC article. Review.
-
Tumor antigens defined by cloned immunological probes are highly polymorphic and are not detected on autologous normal cells.J Exp Med. 1989 Jul 1;170(1):217-32. doi: 10.1084/jem.170.1.217. J Exp Med. 1989. PMID: 2787379 Free PMC article.